activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	616602	CHEMBL811489	Inhibition of TGF-beta type II receptor	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	616602	CHEMBL811489	Inhibition of TGF-beta type II receptor	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1462037	CHEMBL832694	Inhibition of human TGF-beta type II receptor	B	CC(C)OC(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL363058	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1462153	CHEMBL832694	Inhibition of human TGF-beta type II receptor	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362588	=	IC50	nM	3100.0	CHEMBL4267	Homo sapiens	IC50	uM	3.1
	1462175	CHEMBL832694	Inhibition of human TGF-beta type II receptor	B	Cc1cc2c3c(c1)c(C1=C(c4cnc5ccccn45)C(=O)NC1=O)cn3CCN(C(=O)N1CCCCC1)C2		CHEMBL186290	=	IC50	nM	9500.0	CHEMBL4267	Homo sapiens	IC50	uM	9.5
	1462288	CHEMBL832694	Inhibition of human TGF-beta type II receptor	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	IC50	nM	2000.0	CHEMBL4267	Homo sapiens	IC50	uM	2.0
	1462304	CHEMBL832694	Inhibition of human TGF-beta type II receptor	B	CN(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL362814	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1462430	CHEMBL832694	Inhibition of human TGF-beta type II receptor	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	>	IC50	nM	1200.0	CHEMBL4267	Homo sapiens	IC50	uM	1.2
	1691982	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	400.0	CHEMBL4267	Homo sapiens	IC50	uM	0.4
	1692006	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4c(c2)ncn4CCCOC2CCCCO2)CCC3)nc1		CHEMBL204158	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692007	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4c(c2)ncn4CCCOC2CCCCO2)CCC3)n1		CHEMBL202625	=	IC50	nM	14540.0	CHEMBL4267	Homo sapiens	IC50	uM	14.54
	1692008	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cn1cnc2cc(-c3c(-c4ccccn4)nn4c3CCC4)ccc21		CHEMBL203214	=	IC50	nM	19630.0	CHEMBL4267	Homo sapiens	IC50	uM	19.63
	1692009	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4[nH]cnc4c2)CCC3)nc1		CHEMBL204139	=	IC50	nM	8730.0	CHEMBL4267	Homo sapiens	IC50	uM	8.73
	1692010	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCC5)c4c2)CCC3)nc1		CHEMBL378167	=	IC50	nM	10840.0	CHEMBL4267	Homo sapiens	IC50	uM	10.84
	1692011	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	CN(C)CCCn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL202730	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692012	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCCC5)c4c2)CCC3)n1		CHEMBL377711	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692013	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCC5)c4c2)CCC3)n1		CHEMBL206233	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692014	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCOCC5)c4c2)CCC3)n1		CHEMBL381532	=	IC50	nM	19750.0	CHEMBL4267	Homo sapiens	IC50	uM	19.75
	1692015	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	CCN(CC)CCCn1cnc2ccc(-c3c(-c4cccc(C)n4)nn4c3CCC4)cc21		CHEMBL203791	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692016	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN(C)C)c4c2)CCC3)n1		CHEMBL441176	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692017	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	OCCCn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL203619	=	IC50	nM	352.0	CHEMBL4267	Homo sapiens	IC50	uM	0.352
	1692018	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCO)c4c2)CCC3)n1		CHEMBL204063	=	IC50	nM	690.0	CHEMBL4267	Homo sapiens	IC50	uM	0.69
	1692019	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL204170	=	IC50	nM	395.0	CHEMBL4267	Homo sapiens	IC50	uM	0.395
	1692020	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(C)c4c2)CCC3)n1		CHEMBL204966	=	IC50	nM	668.0	CHEMBL4267	Homo sapiens	IC50	uM	0.668
	1692022	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4[nH]cnc4c2)CCC3)n1		CHEMBL382838	=	IC50	nM	1300.0	CHEMBL4267	Homo sapiens	IC50	uM	1.3
	1692023	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cn1ccc2cc(-c3c(-c4ccccn4)nn4c3CCC4)ccc21		CHEMBL427211	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692024	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4c(ccn4C)c2)CCC3)n1		CHEMBL377717	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	1692025	CHEMBL861563	Inhibition of recombinant human TGFbeta R2 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4[nH]ccc4c2)CCC3)nc1		CHEMBL204061	>	IC50	nM	20000.0	CHEMBL4267	Homo sapiens	IC50	uM	20.0
	2470410	CHEMBL981792	Inhibition of TGFBR2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4267	Homo sapiens	INH	%	10.0
	2904289	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2904290	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2904291	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	260.0	CHEMBL4267	Homo sapiens	Kd	nM	260.0
	2905077	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905078	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905079	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	2400.0	CHEMBL4267	Homo sapiens	Kd	nM	2400.0
	2905080	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905081	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905082	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	800.0	CHEMBL4267	Homo sapiens	Kd	nM	800.0
	2905083	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905084	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905085	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2900.0	CHEMBL4267	Homo sapiens	Kd	nM	2900.0
	2905086	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905087	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905088	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	5600.0	CHEMBL4267	Homo sapiens	Kd	nM	5600.0
	2905089	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905090	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905091	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905092	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905093	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905094	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905095	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905096	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905097	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905098	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905099	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905100	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905101	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905102	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905103	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1800.0	CHEMBL4267	Homo sapiens	Kd	nM	1800.0
	2905104	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905105	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905106	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905107	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905108	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905109	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905110	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2905111	CHEMBL1051354	Binding constant for TGFBR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	2922017	CHEMBL1059376	Inhibition of TGFBR2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	2928502	CHEMBL1045670	Binding affinity to TGFBR2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	2.4	CHEMBL4267	Homo sapiens	Activity	%	2.4
	3333188	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3333590	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3334995	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3336415	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3337660	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3338991	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3339247	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3340552	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3341957	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3343404	CHEMBL1168127	Inhibition of TGFBR2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	3351781	CHEMBL1175095	Inhibition of TGFBR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	1.4	CHEMBL4267	Homo sapiens	INH	%	1.4
	3358833	CHEMBL1175095	Inhibition of TGFBR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	1.3	CHEMBL4267	Homo sapiens	INH	%	1.3
	3448648	CHEMBL1245001	Binding affinity to TGFBR2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	3448805	CHEMBL1245001	Binding affinity to TGFBR2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	540.0	CHEMBL4267	Homo sapiens	Kd	nM	540.0
	3449874	CHEMBL1245001	Binding affinity to TGFBR2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	3450259	CHEMBL1245001	Binding affinity to TGFBR2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	3450421	CHEMBL1245001	Binding affinity to TGFBR2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	3450878	CHEMBL1245001	Binding affinity to TGFBR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	3451166	CHEMBL1245001	Binding affinity to TGFBR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	uM	10.0
	3524658	CHEMBL1274126	Inhibition of TGFbeta2 receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	IC50	nM	19000.0	CHEMBL4267	Homo sapiens	IC50	uM	19.0
	6157558	CHEMBL1763571	Inhibition of TGFR2 at 1 uM relative to control	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	IC50	nM	2000.0	CHEMBL4267	Homo sapiens	IC50	uM	2.0
	6158132	CHEMBL1763016	Inhibition of TGFBR2 assessed as inhibition of TGFbeta induced SMAD phosphorylation at 1 uM relative to control	B	Cc1nc(NCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760169	=	Inhibition	%	17.0	CHEMBL4267	Homo sapiens	INH	%	17.0
Not Active	6158133	CHEMBL1763017	Inhibition of TGFBR2 assessed as inhibition of TGFbeta induced SMAD phosphorylation at 10 uM relative to control	B	Cc1nc(NCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760169		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
	6341138	CHEMBL1826995	Activity of TGFBR2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	7567304	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7567763	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7568234	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7568260	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	270.0	CHEMBL4267	Homo sapiens	Kd	nM	270.0
	7568692	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7569277	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7569737	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7570230	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7570657	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7571253	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7571744	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7572207	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7572623	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	250.0	CHEMBL4267	Homo sapiens	Kd	nM	250.0
	7573249	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2900.0	CHEMBL4267	Homo sapiens	Kd	nM	2900.0
	7573725	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2000.0	CHEMBL4267	Homo sapiens	Kd	nM	2000.0
	7574194	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7574602	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7574770	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7575231	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7575702	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	320.0	CHEMBL4267	Homo sapiens	Kd	nM	320.0
	7576167	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	890.0	CHEMBL4267	Homo sapiens	Kd	nM	890.0
	7576575	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1100.0	CHEMBL4267	Homo sapiens	Kd	nM	1100.0
	7576744	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7577203	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7577681	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7578151	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	250.0	CHEMBL4267	Homo sapiens	Kd	nM	250.0
	7578556	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7578752	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7579126	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7579576	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	5600.0	CHEMBL4267	Homo sapiens	Kd	nM	5600.0
	7580050	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7580519	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7581110	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7581495	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7581940	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7582411	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7582833	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7583456	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7583853	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	2400.0	CHEMBL4267	Homo sapiens	Kd	nM	2400.0
	7584298	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7584789	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	330.0	CHEMBL4267	Homo sapiens	Kd	nM	330.0
	7585193	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7585786	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7586194	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7586669	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7587123	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7587747	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7588166	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	540.0	CHEMBL4267	Homo sapiens	Kd	nM	540.0
	7588177	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7588648	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7589099	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1800.0	CHEMBL4267	Homo sapiens	Kd	nM	1800.0
	7590161	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7590635	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7591086	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7591243	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7591665	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7592137	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7592610	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7593063	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7593210	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	260.0	CHEMBL4267	Homo sapiens	Kd	nM	260.0
	7593645	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7594117	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7594590	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7595042	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	6900.0	CHEMBL4267	Homo sapiens	Kd	nM	6900.0
	7595178	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7595622	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	800.0	CHEMBL4267	Homo sapiens	Kd	nM	800.0
	7596096	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7596567	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	3000.0	CHEMBL4267	Homo sapiens	Kd	nM	3000.0
	7597150	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7597603	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7598076	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	7598546	CHEMBL1908606	Binding constant for TGFBR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL4267	Homo sapiens	Kd	nM	10000.0
	8012923	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945557	=	Delta Tm	degrees C	0.3	CHEMBL4267	Homo sapiens	deltaTm	degrees C	0.3
	8013020	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(CN)C(C)(C)NC2=O		CHEMBL1945561	=	Delta Tm	degrees C	3.0	CHEMBL4267	Homo sapiens	deltaTm	degrees C	3.0
	8013045	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC(=O)NCC1c2c(n(C)c3c(Cl)c(Cl)ccc23)C(=O)NC1(C)C		CHEMBL1945562	=	Delta Tm	degrees C	1.5	CHEMBL4267	Homo sapiens	deltaTm	degrees C	1.5
	8027524	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc[nH]c(=O)c21		CHEMBL474872	=	Delta Tm	degrees C	10.1	CHEMBL4267	Homo sapiens	deltaTm	degrees C	10.1
	8027549	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc(N)[nH]c(=O)c21		CHEMBL1945336	=	Delta Tm	degrees C	7.9	CHEMBL4267	Homo sapiens	deltaTm	degrees C	7.9
	8027574	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C(C)(C)NC2=O		CHEMBL1945337	=	Delta Tm	degrees C	8.1	CHEMBL4267	Homo sapiens	deltaTm	degrees C	8.1
	8027599	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC1(C)NC(=O)c2[nH]c3c(Cl)c(Cl)ccc3c2C1C#N		CHEMBL1945338	=	Delta Tm	degrees C	6.8	CHEMBL4267	Homo sapiens	deltaTm	degrees C	6.8
	8027624	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCC1(CC)NC(=O)c2c(c3ccc(Cl)c(Cl)c3n2C)C1C#N		CHEMBL1945339	=	Delta Tm	degrees C	5.0	CHEMBL4267	Homo sapiens	deltaTm	degrees C	5.0
	8027649	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccccc31)C(C#N)C(C)(C)NC2=O		CHEMBL1945340	=	Delta Tm	degrees C	2.9	CHEMBL4267	Homo sapiens	deltaTm	degrees C	2.9
	8027685	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCC1)NC2=O		CHEMBL1945554	=	Delta Tm	degrees C	2.2	CHEMBL4267	Homo sapiens	deltaTm	degrees C	2.2
	8027710	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCOCC1)NC2=O		CHEMBL1945335	=	Delta Tm	degrees C	2.6	CHEMBL4267	Homo sapiens	deltaTm	degrees C	2.6
	8027735	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cn[nH]c(=O)c21		CHEMBL1945555	=	Delta Tm	degrees C	10.4	CHEMBL4267	Homo sapiens	deltaTm	degrees C	10.4
	8027760	CHEMBL1947294	Binding affinity to TGFBR2 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945556	=	Delta Tm	degrees C	1.1	CHEMBL4267	Homo sapiens	deltaTm	degrees C	1.1
	12081729	CHEMBL2166436	Inhibition of TGFB-R2 assessed as residual enzyme activity at 10 uM by radiometric protein kinase assay	B	Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-]		CHEMBL2164692	=	Activity	%	6.0	CHEMBL4267	Homo sapiens	Activity	%	6.0
	12163043	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OCC(C)C)C2c1ccc(C(C)(C)C)cc1		CHEMBL2180267	=	Inhibition	%	94.0	CHEMBL4267	Homo sapiens	INH	%	94.0
	12163044	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OCC)C2c1ccc(C(C)(C)C)cc1		CHEMBL2180266	=	Inhibition	%	98.0	CHEMBL4267	Homo sapiens	INH	%	98.0
Active	12163045	CHEMBL2182422	Induction of degradation of HA-tagged TGFBR2 expressed in HEK293T cells at 2.5 uM after 20 hrs by flow cytometry	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274		Activity			CHEMBL4267	Homo sapiens	Activity		
Active	12163046	CHEMBL2182422	Induction of degradation of HA-tagged TGFBR2 expressed in HEK293T cells at 2.5 uM after 20 hrs by flow cytometry	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274		Activity			CHEMBL4267	Homo sapiens	Activity		
Active	12163047	CHEMBL2182422	Induction of degradation of HA-tagged TGFBR2 expressed in HEK293T cells at 2.5 uM after 20 hrs by flow cytometry	B	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180273		Activity			CHEMBL4267	Homo sapiens	Activity		
Active	12163048	CHEMBL2182422	Induction of degradation of HA-tagged TGFBR2 expressed in HEK293T cells at 2.5 uM after 20 hrs by flow cytometry	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2180268		Activity			CHEMBL4267	Homo sapiens	Activity		
	12163067	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274	=	Inhibition	%	60.0	CHEMBL4267	Homo sapiens	INH	%	60.0
	12163068	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274	=	Inhibition	%	54.0	CHEMBL4267	Homo sapiens	INH	%	54.0
	12163069	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2180268	=	Inhibition	%	97.0	CHEMBL4267	Homo sapiens	INH	%	97.0
	12163070	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2180268	=	Inhibition	%	49.0	CHEMBL4267	Homo sapiens	INH	%	49.0
	12163071	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180273	=	Inhibition	%	95.0	CHEMBL4267	Homo sapiens	INH	%	95.0
	12163072	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180273	=	Inhibition	%	30.0	CHEMBL4267	Homo sapiens	INH	%	30.0
	12163073	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274	=	IC50	nM	2030.0	CHEMBL4267	Homo sapiens	IC50	uM	2.03
	12163074	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274	=	IC50	nM	2640.0	CHEMBL4267	Homo sapiens	IC50	uM	2.64
	12163075	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2180268	=	IC50	nM	400.0	CHEMBL4267	Homo sapiens	IC50	uM	0.4
	12163076	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2180268	=	IC50	nM	4060.0	CHEMBL4267	Homo sapiens	IC50	uM	4.06
	12163077	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180273	=	IC50	nM	460.0	CHEMBL4267	Homo sapiens	IC50	uM	0.46
	12163078	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180273	=	IC50	nM	6900.0	CHEMBL4267	Homo sapiens	IC50	uM	6.9
	12163079	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	66.0	CHEMBL4267	Homo sapiens	IC50	uM	0.066
	12163082	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OCC(C)C)C2c1ccc(C(C)(C)C)cc1		CHEMBL2180267	=	IC50	nM	170.0	CHEMBL4267	Homo sapiens	IC50	uM	0.17
	12163083	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OCC)C2c1ccc(C(C)(C)C)cc1		CHEMBL2180266	=	IC50	nM	170.0	CHEMBL4267	Homo sapiens	IC50	uM	0.17
	12163084	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(N(C)C)cc3)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180272	=	Inhibition	%	40.0	CHEMBL4267	Homo sapiens	INH	%	40.0
	12163085	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180271	=	Inhibition	%	61.0	CHEMBL4267	Homo sapiens	INH	%	61.0
	12163086	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(CC(C)C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180270	=	Inhibition	%	94.0	CHEMBL4267	Homo sapiens	INH	%	94.0
	12163087	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C(C)C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180269	=	Inhibition	%	83.0	CHEMBL4267	Homo sapiens	INH	%	83.0
	12163088	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2180268	=	Inhibition	%	96.0	CHEMBL4267	Homo sapiens	INH	%	96.0
	12163089	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2177136	=	Inhibition	%	92.0	CHEMBL4267	Homo sapiens	INH	%	92.0
	12163090	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180286	=	Inhibition	%	48.0	CHEMBL4267	Homo sapiens	INH	%	48.0
	12163091	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1=C(C(=O)OCC)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180285	=	Inhibition	%	88.0	CHEMBL4267	Homo sapiens	INH	%	88.0
	12163092	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COc1ccc(CNC(=O)C2=C(C)NC3=C(C(=O)CC(C)(C)C3)C2c2ccc(-c3ccccc3)cc2)cc1		CHEMBL2180284	=	Inhibition	%	40.0	CHEMBL4267	Homo sapiens	INH	%	40.0
	12163093	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COc1ccc(COC(=O)C2=C(C)NC3=C(C(=O)CC(C)(C)C3)C2c2ccc(-c3ccccc3)cc2)cc1		CHEMBL2180283	=	Inhibition	%	72.0	CHEMBL4267	Homo sapiens	INH	%	72.0
	12163094	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)OCCC(C)C)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180282	=	Inhibition	%	71.0	CHEMBL4267	Homo sapiens	INH	%	71.0
	12163095	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)OCC(C)C)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180281	=	Inhibition	%	87.0	CHEMBL4267	Homo sapiens	INH	%	87.0
	12163096	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)OCC(F)(F)F)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180280	=	Inhibition	%	85.0	CHEMBL4267	Homo sapiens	INH	%	85.0
	12163097	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)O)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180279	=	Inhibition	%	21.0	CHEMBL4267	Homo sapiens	INH	%	21.0
	12163098	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(N(C)C)cc3)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180272	=	IC50	nM	3970.0	CHEMBL4267	Homo sapiens	IC50	uM	3.97
	12163099	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180271	=	IC50	nM	1920.0	CHEMBL4267	Homo sapiens	IC50	uM	1.92
	12163100	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(CC(C)C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180270	=	IC50	nM	590.0	CHEMBL4267	Homo sapiens	IC50	uM	0.59
	12163101	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C(C)C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180269	=	IC50	nM	940.0	CHEMBL4267	Homo sapiens	IC50	uM	0.94
	12163102	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2180268	=	IC50	nM	530.0	CHEMBL4267	Homo sapiens	IC50	uM	0.53
	12163103	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCC1CC(=O)C2=C(C1)NC(C)=C(C(=O)OC)C2c1ccc(-c2ccccc2)cc1		CHEMBL2177136	=	IC50	nM	790.0	CHEMBL4267	Homo sapiens	IC50	uM	0.79
	12163104	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180286	=	IC50	nM	2730.0	CHEMBL4267	Homo sapiens	IC50	uM	2.73
	12163105	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCCC1=C(C(=O)OCC)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180285	=	IC50	nM	830.0	CHEMBL4267	Homo sapiens	IC50	uM	0.83
	12163106	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COc1ccc(CNC(=O)C2=C(C)NC3=C(C(=O)CC(C)(C)C3)C2c2ccc(-c3ccccc3)cc2)cc1		CHEMBL2180284	=	IC50	nM	4060.0	CHEMBL4267	Homo sapiens	IC50	uM	4.06
	12163107	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COc1ccc(COC(=O)C2=C(C)NC3=C(C(=O)CC(C)(C)C3)C2c2ccc(-c3ccccc3)cc2)cc1		CHEMBL2180283	=	IC50	nM	830.0	CHEMBL4267	Homo sapiens	IC50	uM	0.83
	12163108	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)OCCC(C)C)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180282	=	IC50	nM	1460.0	CHEMBL4267	Homo sapiens	IC50	uM	1.46
	12163109	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)OCC(C)C)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180281	=	IC50	nM	530.0	CHEMBL4267	Homo sapiens	IC50	uM	0.53
	12163110	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)OCC(F)(F)F)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180280	=	IC50	nM	760.0	CHEMBL4267	Homo sapiens	IC50	uM	0.76
	12163111	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CC1=C(C(=O)O)C(c2ccc(-c3ccccc3)cc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL2180279	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	12163112	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274	=	Inhibition	%	45.0	CHEMBL4267	Homo sapiens	INH	%	45.0
	12163113	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2cccnc2)c1		CHEMBL2180278	=	Inhibition	%	10.0	CHEMBL4267	Homo sapiens	INH	%	10.0
	12163114	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2cccc(Cl)c2)c1		CHEMBL2180277	=	Inhibition	%	27.0	CHEMBL4267	Homo sapiens	INH	%	27.0
	12163115	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc(OC)cc2)c1		CHEMBL2180276	=	Inhibition	%	5.0	CHEMBL4267	Homo sapiens	INH	%	5.0
	12163116	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccccc2)c1		CHEMBL2180275	=	Inhibition	%	18.0	CHEMBL4267	Homo sapiens	INH	%	18.0
	12163117	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2F)cc1		CHEMBL2180615	=	Inhibition	%	58.0	CHEMBL4267	Homo sapiens	INH	%	58.0
	12163118	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2C)cc1		CHEMBL2180614	=	Inhibition	%	87.0	CHEMBL4267	Homo sapiens	INH	%	87.0
	12163119	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2cccc(Cl)c2)cc1		CHEMBL2180613	=	Inhibition	%	73.0	CHEMBL4267	Homo sapiens	INH	%	73.0
	12163120	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc(C(F)(F)F)cc2)cc1		CHEMBL2180612	=	Inhibition	%	91.0	CHEMBL4267	Homo sapiens	INH	%	91.0
	12163121	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc(C)cc2)cc1		CHEMBL2180611	=	Inhibition	%	88.0	CHEMBL4267	Homo sapiens	INH	%	88.0
	12163122	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc(C(=O)OC)cc2)cc1		CHEMBL2180610	=	Inhibition	%	78.0	CHEMBL4267	Homo sapiens	INH	%	78.0
	12163123	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)c(F)c1		CHEMBL2180609	=	Inhibition	%	59.0	CHEMBL4267	Homo sapiens	INH	%	59.0
	12163124	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc3[nH]ccc3c2)c1		CHEMBL2180274	=	IC50	nM	4450.0	CHEMBL4267	Homo sapiens	IC50	uM	4.45
	12163125	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2cccnc2)c1		CHEMBL2180278	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	12163126	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2cccc(Cl)c2)c1		CHEMBL2180277	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	12163127	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccc(OC)cc2)c1		CHEMBL2180276	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	12163128	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1cccc(-c2ccccc2)c1		CHEMBL2180275	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	12163129	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2F)cc1		CHEMBL2180615	=	IC50	nM	2060.0	CHEMBL4267	Homo sapiens	IC50	uM	2.06
	12163130	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2C)cc1		CHEMBL2180614	=	IC50	nM	890.0	CHEMBL4267	Homo sapiens	IC50	uM	0.89
	12163131	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2cccc(Cl)c2)cc1		CHEMBL2180613	=	IC50	nM	1520.0	CHEMBL4267	Homo sapiens	IC50	uM	1.52
	12163132	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc(C(F)(F)F)cc2)cc1		CHEMBL2180612	=	IC50	nM	730.0	CHEMBL4267	Homo sapiens	IC50	uM	0.73
	12163133	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc(C)cc2)cc1		CHEMBL2180611	=	IC50	nM	860.0	CHEMBL4267	Homo sapiens	IC50	uM	0.86
	12163134	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc(C(=O)OC)cc2)cc1		CHEMBL2180610	=	IC50	nM	1350.0	CHEMBL4267	Homo sapiens	IC50	uM	1.35
	12163135	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)c(F)c1		CHEMBL2180609	=	IC50	nM	1840.0	CHEMBL4267	Homo sapiens	IC50	uM	1.84
	12163136	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc3[nH]ccc3c2)cc1		CHEMBL2180608	=	Inhibition	%	41.0	CHEMBL4267	Homo sapiens	INH	%	41.0
	12163137	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(CC)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccn2)cc1		CHEMBL2180290	=	Inhibition	%	41.0	CHEMBL4267	Homo sapiens	INH	%	41.0
	12163138	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-n2cccn2)cc1		CHEMBL2180289	=	Inhibition	%	18.0	CHEMBL4267	Homo sapiens	INH	%	18.0
	12163139	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180273	=	Inhibition	%	83.0	CHEMBL4267	Homo sapiens	INH	%	83.0
	12163140	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180288	=	Inhibition	%	44.0	CHEMBL4267	Homo sapiens	INH	%	44.0
	12163141	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(C2CCCCC2)cc1		CHEMBL2180287	=	Inhibition	%	94.0	CHEMBL4267	Homo sapiens	INH	%	94.0
	12163142	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(C(C)(C)C)cc1		CHEMBL2180618	=	Inhibition	%	79.0	CHEMBL4267	Homo sapiens	INH	%	79.0
	12163143	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccccc1		CHEMBL2180617	=	Inhibition	%	6.0	CHEMBL4267	Homo sapiens	INH	%	6.0
	12163144	CHEMBL2182429	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation at 2.5 uM after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(F)cc1		CHEMBL2180616	=	Inhibition	%	4.0	CHEMBL4267	Homo sapiens	INH	%	4.0
	12163145	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccc3[nH]ccc3c2)cc1		CHEMBL2180608	=	IC50	nM	4050.0	CHEMBL4267	Homo sapiens	IC50	uM	4.05
	12163146	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(CC)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccn2)cc1		CHEMBL2180290	=	IC50	nM	3570.0	CHEMBL4267	Homo sapiens	IC50	uM	3.57
	12163147	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-n2cccn2)cc1		CHEMBL2180289	=	IC50	nM	8800.0	CHEMBL4267	Homo sapiens	IC50	uM	8.8
	12163148	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180273	=	IC50	nM	850.0	CHEMBL4267	Homo sapiens	IC50	uM	0.85
	12163149	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1		CHEMBL2180288	=	IC50	nM	1490.0	CHEMBL4267	Homo sapiens	IC50	uM	1.49
	12163150	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(C2CCCCC2)cc1		CHEMBL2180287	=	IC50	nM	590.0	CHEMBL4267	Homo sapiens	IC50	uM	0.59
	12163151	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(C(C)(C)C)cc1		CHEMBL2180618	=	IC50	nM	560.0	CHEMBL4267	Homo sapiens	IC50	uM	0.56
	12163152	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccccc1		CHEMBL2180617	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	12163153	CHEMBL2182430	Inhibition of TGBR2 signaling in human HEK293T cells assessed as inhibition of SMAD activation after 2 to 22 hrs by dual Luciferase Assay	B	COC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(F)cc1		CHEMBL2180616	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	12172182	CHEMBL2209260	Inhibition of TGFBR2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	89.0	CHEMBL4267	Homo sapiens	Activity	%	89.0
	12197273	CHEMBL2209976	Inhibition of TGF-beta1 induced TGF-beta type 2 receptor dimerization in human HeLa cells assessed as receptor dimers by bleaching-step counting assay (Rvb = 39.9 +/- 2.5%)	B	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O		CHEMBL399121	=	Activity	%	19.5	CHEMBL4267	Homo sapiens	Activity	%	19.5
Not Active	12197274	CHEMBL2209977	Inhibition of TGF-beta type 2 receptor dimerization in human HeLa cells at 100 uM after 1 hr by single-molecule fluorescence microscopy	B	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O		CHEMBL399121		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
	12197281	CHEMBL2209558	Inhibition of TGF-beta1 induced TGF-beta type 2 receptor dimerization in human HeLa cells at 100 uM after 1 hr by single-molecule fluorescence microscopy	B	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O		CHEMBL399121	=	Inhibition	%	19.9	CHEMBL4267	Homo sapiens	INH	%	19.9
Active	12197282	CHEMBL2209557	Displacement of biotinylated TGF-beta1 from human TGF-beta type 2 receptor at 100 uM after 1 hr by avidin-FITC-based flow cytometry	B	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O		CHEMBL399121		Activity			CHEMBL4267	Homo sapiens	Activity		
	12197283	CHEMBL2209556	Inhibition of TGF-beta1 ligand binding to TGF-beta type 2 receptor in human HeLa cells at 100 uM after 1 hr by atomic force microscopy (Rvb = 23.4 +/- 2.5%)	B	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O		CHEMBL399121	=	Inhibition	%	10.5	CHEMBL4267	Homo sapiens	INH	%	10.5
Not Active	13321758	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1		CHEMBL502351		IC50			CHEMBL4267	Homo sapiens	IC50		
Not Active	13321759	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL2385597		IC50			CHEMBL4267	Homo sapiens	IC50		
	13321836	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)c2cccnc2c1		CHEMBL2385591	=	IC50	nM	327.0	CHEMBL4267	Homo sapiens	IC50	nM	327.0
	13321840	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL511563	=	IC50	nM	236.0	CHEMBL4267	Homo sapiens	IC50	nM	236.0
	13321849	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	140.4	CHEMBL4267	Homo sapiens	IC50	nM	140.4
	13321855	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	102.9	CHEMBL4267	Homo sapiens	IC50	nM	102.9
	13322773	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	c1cc(N2CCNCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385586	=	IC50	nM	38.0	CHEMBL4267	Homo sapiens	IC50	nM	38.0
	13322779	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCOCC6)cc5)cnc34)ccnc2c1		CHEMBL2385582	=	IC50	nM	26.0	CHEMBL4267	Homo sapiens	IC50	nM	26.0
	13322783	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)cc1		CHEMBL2385600	=	IC50	nM	16.0	CHEMBL4267	Homo sapiens	IC50	nM	16.0
	13322785	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	CN1CCN(c2ccc(-c3cnc4c(-c5ccnc6ccccc56)cnn4c3)cc2)CC1		CHEMBL2385596	=	IC50	nM	15.0	CHEMBL4267	Homo sapiens	IC50	nM	15.0
	13322796	CHEMBL2390518	Inhibition of TGFBR2 (unknown origin)	B	c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385579	=	IC50	nM	1.37	CHEMBL4267	Homo sapiens	IC50	nM	1.37
	13439741	CHEMBL2428982	Competitive binding affinity to TGFBR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	13445574	CHEMBL2428982	Competitive binding affinity to TGFBR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
	13451561	CHEMBL2428982	Competitive binding affinity to TGFBR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	96.0	CHEMBL4267	Homo sapiens	INH	%	96.0
Not Active	13863470	CHEMBL3101872	Inhibition of TGFBR2 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
Not Active	13863471	CHEMBL3101872	Inhibition of TGFBR2 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
Not Active	14545560	CHEMBL3225606	Binding affinity to human TGFbetaR2 (amino acid residues M1 to D159) at 0.125 to 2 uM by surface plasmon resonance assay	B	CCCCCCCCCCCCCCCCCC(=O)OCC(CO[C@@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC.[Na+]		CHEMBL3219622		Activity			CHEMBL4267	Homo sapiens	Activity		
	14659720	CHEMBL3269193	Inhibition of TGFbetaR2 (unknown origin) assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	87.0	CHEMBL4267	Homo sapiens	Activity	%	87.0
	14659721	CHEMBL3269194	Inhibition of TGFbetaR2 (unknown origin) assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	84.0	CHEMBL4267	Homo sapiens	Activity	%	84.0
	14659722	CHEMBL3269195	Inhibition of TGFbetaR2 (unknown origin) assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	47.0	CHEMBL4267	Homo sapiens	Activity	%	47.0
	14659723	CHEMBL3269196	Inhibition of TGFbetaR2 (unknown origin) assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	8.0	CHEMBL4267	Homo sapiens	Activity	%	8.0
	15058837	CHEMBL3371391	Inhibition of TGFBR2 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	28.0	CHEMBL4267	Homo sapiens	Activity	%	28.0
	15756790	CHEMBL3631496	Inhibition of TGFBR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-25.92	CHEMBL4267	Homo sapiens	INH	%	-25.92
	15757933	CHEMBL3631496	Inhibition of TGFBR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	96.61	CHEMBL4267	Homo sapiens	INH	%	96.61
	15758912	CHEMBL3631496	Inhibition of TGFBR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-28.96	CHEMBL4267	Homo sapiens	INH	%	-28.96
	16432028	CHEMBL3750182	Inhibition of human TGFBR2 using MBP substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	16614647	CHEMBL3816863	Inhibition of human TGFBR2 at 1 uM using MBP substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	0.0	CHEMBL4267	Homo sapiens	INH	%	0.0
Inactive	17944787	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944788	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944789	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1384.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	1384.0
Inactive	17944790	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944791	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944792	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944793	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944794	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944795	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944796	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944797	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944798	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944799	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944800	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944801	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944802	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944803	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944804	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944805	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944806	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944807	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944808	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944809	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944810	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944811	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944812	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944813	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944814	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944815	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944816	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944817	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944818	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944819	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944820	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944821	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944822	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944823	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944824	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944825	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944826	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944827	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944828	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944829	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3121.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	3121.0
Inactive	17944830	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944831	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944832	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	1779.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	1779.0
Inactive	17944833	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944834	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944835	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944836	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944837	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944838	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944839	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944840	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944841	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944842	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944843	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944844	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944845	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944846	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944847	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944848	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944849	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944850	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944851	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944852	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944853	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944854	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944855	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944856	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944857	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944858	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944859	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944860	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944861	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944862	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944863	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944864	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944865	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944866	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944867	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944868	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944869	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944870	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	863.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	863.0
Inactive	17944871	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944872	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944873	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944874	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944875	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944876	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944877	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1280.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	1280.0
Inactive	17944878	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944879	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	2534.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	2534.0
Inactive	17944880	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944881	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944882	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944883	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944884	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944885	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944886	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944887	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944888	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944889	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944890	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944891	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944892	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944893	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944894	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944895	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944896	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	703.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	703.0
Inactive	17944897	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944898	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944899	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944900	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944901	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944902	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944903	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944904	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944905	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944906	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944907	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944908	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944909	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944910	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944911	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944912	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944913	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944914	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944915	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944916	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944917	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944918	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944919	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944920	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944921	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944922	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944923	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944924	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944925	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944926	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944927	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944928	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944929	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944930	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944931	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944932	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944933	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944934	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	80.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	80.0
Inactive	17944935	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944936	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944937	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944938	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944939	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944940	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944941	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17944942	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	1641.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	1641.0
Inactive	17944943	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944944	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944945	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944946	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944947	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944948	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944949	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944950	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	300.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	300.0
Inactive	17944951	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944952	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944953	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944954	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944955	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944956	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944957	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944958	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944959	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944960	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944961	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944962	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944963	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944964	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944965	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944966	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	=	Kd	nM	3396.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	3396.0
Inactive	17944967	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944968	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	2348.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	2348.0
Inactive	17944969	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944970	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944971	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944972	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944973	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944974	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944975	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944976	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944977	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944978	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944979	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944980	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944981	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944982	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944983	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944984	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944985	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944986	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944987	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944988	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944989	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Active	17944990	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	4725.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	4725.0
Active	17944991	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	146.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	146.0
Inactive	17944992	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944993	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944994	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944995	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944996	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944997	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944998	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944999	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945000	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945001	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945002	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945003	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945004	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945005	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945006	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945007	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945008	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945009	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945010	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945011	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945012	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945013	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945014	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945015	CHEMBL3991910	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4267	Homo sapiens	Kd apparent	nM	30000.0
	17982176	CHEMBL3998823	Inhibition of human TGFbetaR2 at 1 uM using myelin basic protein as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	Inhibition	%	80.0	CHEMBL4267	Homo sapiens	INH	%	80.0
	18114880	CHEMBL4025410	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	90.0	CHEMBL4267	Homo sapiens	Activity	%	90.0
	18203934	CHEMBL4044221	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	91.0	CHEMBL4267	Homo sapiens	Activity	%	91.0
	18225233	CHEMBL4048697	Inhibition of TGFBR2 (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCCC2)NC3=O)ncn1		CHEMBL4076439	=	Inhibition	%	57.0	CHEMBL4267	Homo sapiens	INH	%	57.0
	18225374	CHEMBL4048697	Inhibition of TGFBR2 (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	74.0	CHEMBL4267	Homo sapiens	INH	%	74.0
	18253963	CHEMBL4055266	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	18253964	CHEMBL4055266	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	18275377	CHEMBL4118511	Inhibition of human TGFBR2 (218 to 567 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	3.8	CHEMBL4267	Homo sapiens	Activity	%	3.8
	18276149	CHEMBL4119079	Inhibition of human TGFBR2 (218 to 567 residues) expressed in bacterial expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.9	CHEMBL4267	Homo sapiens	Activity	%	0.9
	18407919	CHEMBL4151475	Inhibition of human TGFBR2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	91.0	CHEMBL4267	Homo sapiens	Activity	%	91.0
	18407960	CHEMBL4151475	Inhibition of human TGFBR2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	17.0	CHEMBL4267	Homo sapiens	Activity	%	17.0
	18408005	CHEMBL4151475	Inhibition of human TGFBR2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	78.0	CHEMBL4267	Homo sapiens	Activity	%	78.0
	18440476	CHEMBL4157300	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	18450297	CHEMBL4178281	Inhibition of recombinant N-terminal GST-tagged TGFBR2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	2.0	CHEMBL4267	Homo sapiens	Activity	%	2.0
	18450347	CHEMBL4178281	Inhibition of recombinant N-terminal GST-tagged TGFBR2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	3.0	CHEMBL4267	Homo sapiens	Activity	%	3.0
	18484432	CHEMBL4186079	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL4267	Homo sapiens	Activity	%	96.0
	18484916	CHEMBL4186079	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	18496570	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Fc1cnccc1Nc1nc(-c2cccc(C(F)(F)F)n2)nc2[nH]ccc12		CHEMBL4217699	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18496571	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]ccc23)ccn1		CHEMBL4209583	=	IC50	nM	940.0	CHEMBL4267	Homo sapiens	IC50	uM	0.94
Not Determined	18496572	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]cnc23)ccn1		CHEMBL4205456		IC50			CHEMBL4267	Homo sapiens	IC50		
	18496573	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3cc[nH]c3n2)n1		CHEMBL4210246	=	IC50	nM	310.0	CHEMBL4267	Homo sapiens	IC50	uM	0.31
	18496574	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3nc[nH]c3n2)n1		CHEMBL4209835	=	IC50	nM	1100.0	CHEMBL4267	Homo sapiens	IC50	uM	1.1
	18496575	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	=	IC50	nM	190.0	CHEMBL4267	Homo sapiens	IC50	uM	0.19
Not Determined	18496576	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	O=C(CN1CCN(CCO)CC1)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nn3cccc23)ccn1		CHEMBL4214237		IC50			CHEMBL4267	Homo sapiens	IC50		
	18496577	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nn3cccc23)c(F)cn1		CHEMBL4206910	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
Not Determined	18496578	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nn3cccc23)ccn1		CHEMBL4216706		IC50			CHEMBL4267	Homo sapiens	IC50		
	18496579	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	N[C@@H]1CCN(Cc2ccn3nc(-c4ccccn4)nc(Nc4ccncc4F)c23)C[C@H]1O		CHEMBL4217935	=	IC50	nM	3000.0	CHEMBL4267	Homo sapiens	IC50	uM	3.0
	18496580	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	N[C@H]1CCN(Cc2ccn3nc(-c4ccccn4)nc(Nc4ccncc4F)c23)C[C@@H]1O		CHEMBL4206220	=	IC50	nM	810.0	CHEMBL4267	Homo sapiens	IC50	uM	0.81
	18496581	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	N[C@H]1CC[C@@H](NCc2ccn3nc(-c4ccccn4)nc(Nc4ccncc4F)c23)CC1		CHEMBL4214470	=	IC50	nM	2000.0	CHEMBL4267	Homo sapiens	IC50	uM	2.0
	18496582	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Fc1cnccc1Nc1nc(-c2ccccn2)nn2cccc12		CHEMBL4204772	=	IC50	nM	110.0	CHEMBL4267	Homo sapiens	IC50	uM	0.11
	18496583	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3C(=O)NC(C)C)c3cccn3n2)n1		CHEMBL4210079	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18496584	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3c(F)cncc3F)c3cccn3n2)n1		CHEMBL4211574	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18496585	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3cccn3n2)n1		CHEMBL4205457	=	IC50	nM	570.0	CHEMBL4267	Homo sapiens	IC50	uM	0.57
	18496586	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	FC(F)(F)c1cccc(-c2nc(Nc3ccncc3)c3cccn3n2)n1		CHEMBL4202469	=	IC50	nM	8500.0	CHEMBL4267	Homo sapiens	IC50	uM	8.5
	18496587	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	COc1cccc(-c2nc(Nc3ccncc3)c3cccn3n2)n1		CHEMBL4218893	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18496588	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	c1ccc(-c2nc(Nc3ccncc3)c3cccn3n2)nc1		CHEMBL4205311	=	IC50	nM	77.0	CHEMBL4267	Homo sapiens	IC50	uM	0.077
	18496589	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3)c3cccn3n2)n1		CHEMBL4206793	=	IC50	nM	550.0	CHEMBL4267	Homo sapiens	IC50	uM	0.55
	18496610	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccnc4ccccc34)c3cccn3n2)n1		CHEMBL4205979	=	IC50	nM	1100.0	CHEMBL4267	Homo sapiens	IC50	uM	1.1
	18496612	CHEMBL4188412	Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	1300.0	CHEMBL4267	Homo sapiens	IC50	uM	1.3
	18655256	CHEMBL4230979	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	18751373	CHEMBL4263990	Inhibition of recombinant N-terminal GST-tagged human TGFbetaR2 expressed in Baculovirus expression system by LanthaScreen assay	B	CC(c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1)N1CCCC1		CHEMBL4283638	=	IC50	nM	698.0	CHEMBL4267	Homo sapiens	IC50	nM	698.0
	18752231	CHEMBL4264568	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	18782474	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	[2H]C([2H])([2H])Oc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4280731	=	IC50	nM	7600.0	CHEMBL4267	Homo sapiens	IC50	uM	7.6
	18782475	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C)n2)ccn1		CHEMBL4292047	=	IC50	nM	730.0	CHEMBL4267	Homo sapiens	IC50	uM	0.73
	18782476	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)F)n2)ccn1		CHEMBL4284170	=	IC50	nM	4300.0	CHEMBL4267	Homo sapiens	IC50	uM	4.3
	18782477	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)(F)F)n2)ccn1		CHEMBL4276907	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18782501	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	COc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4288634	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18782502	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(OC(F)F)cn2)ccn1		CHEMBL4277338	=	IC50	nM	14000.0	CHEMBL4267	Homo sapiens	IC50	uM	14.0
	18782503	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(C)cn2)ccn1		CHEMBL4285292	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18782504	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(Cl)cn2)ccn1		CHEMBL4280660	=	IC50	nM	14000.0	CHEMBL4267	Homo sapiens	IC50	uM	14.0
	18782505	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cn2)ccn1		CHEMBL4291307	=	IC50	nM	390.0	CHEMBL4267	Homo sapiens	IC50	uM	0.39
	18782506	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	COc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)cn1		CHEMBL4279160	=	IC50	nM	40.0	CHEMBL4267	Homo sapiens	IC50	uM	0.04
	18782507	CHEMBL4270415	Inhibition of wild type TGFbetaR2 (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)nc2)ccn1		CHEMBL4289841	=	IC50	nM	7.0	CHEMBL4267	Homo sapiens	IC50	uM	0.007
	18858231	CHEMBL4308077	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	92.0	CHEMBL4267	Homo sapiens	Activity	%	92.0
	18892724	CHEMBL4314525	Inhibition of human TGFBR2 (188 to end residues) using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	71.0	CHEMBL4267	Homo sapiens	Activity	%	71.0
	18919391	CHEMBL4322751	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged TGFBR2 (unknown origin) (194 to 567 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	854.0	CHEMBL4267	Homo sapiens	Kd	nM	854.0
	18919579	CHEMBL4322751	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged TGFBR2 (unknown origin) (194 to 567 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	>	Kd	nM	2000.0	CHEMBL4267	Homo sapiens	Kd	nM	2000.0
	18938353	CHEMBL4327903	Inhibition of human TGFBR2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.61	CHEMBL4267	Homo sapiens	Activity	%	101.61
	18938354	CHEMBL4327903	Inhibition of human TGFBR2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	111.2	CHEMBL4267	Homo sapiens	Activity	%	111.2
	18938748	CHEMBL4328267	Inhibition of human TGFBR2 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	<	Activity	%	65.0	CHEMBL4267	Homo sapiens	Activity	%	65.0
Not Determined	18939134	CHEMBL4328631	Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL4267	Homo sapiens	IC50		
	18939135	CHEMBL4328631	Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	156.0	CHEMBL4267	Homo sapiens	IC50	10'-7M	1.56
	18959003	CHEMBL4333659	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	18964745	CHEMBL4335314	Inhibition of human TGFBR2 (188 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	61.0	CHEMBL4267	Homo sapiens	Activity	%	61.0
	18964746	CHEMBL4335314	Inhibition of human TGFBR2 (188 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	90.0	CHEMBL4267	Homo sapiens	Activity	%	90.0
	18972128	CHEMBL4337138	Inhibition of recombinant human TGFBR2 (188 to end residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 120 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	87.0	CHEMBL4267	Homo sapiens	Activity	%	87.0
	18980210	CHEMBL4339025	Inhibition of wild type His-tagged TGFBR2 kinase domain (unknown origin) incubated for 1 hr by HTRF analysis	B	Cc1cccc(-c2ncn(C)c2-c2ccc3nccn3c2)c1		CHEMBL4534989	=	IC50	nM	5710.0	CHEMBL4267	Homo sapiens	IC50	uM	5.71
	18980211	CHEMBL4339025	Inhibition of wild type His-tagged TGFBR2 kinase domain (unknown origin) incubated for 1 hr by HTRF analysis	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3nccn3c2)n1		CHEMBL4458215	=	IC50	nM	12900.0	CHEMBL4267	Homo sapiens	IC50	uM	12.9
	18980212	CHEMBL4339025	Inhibition of wild type His-tagged TGFBR2 kinase domain (unknown origin) incubated for 1 hr by HTRF analysis	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3ncc(C(N)=O)n3c2)n1		CHEMBL4455462	=	IC50	nM	820.0	CHEMBL4267	Homo sapiens	IC50	uM	0.82
	18980213	CHEMBL4339025	Inhibition of wild type His-tagged TGFBR2 kinase domain (unknown origin) incubated for 1 hr by HTRF analysis	B	NC(=O)c1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4440988	=	IC50	nM	2930.0	CHEMBL4267	Homo sapiens	IC50	uM	2.93
	18980214	CHEMBL4339025	Inhibition of wild type His-tagged TGFBR2 kinase domain (unknown origin) incubated for 1 hr by HTRF analysis	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4584495	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18980215	CHEMBL4339025	Inhibition of wild type His-tagged TGFBR2 kinase domain (unknown origin) incubated for 1 hr by HTRF analysis	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CCO)nn12		CHEMBL4452178	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
	18980216	CHEMBL4339025	Inhibition of wild type His-tagged TGFBR2 kinase domain (unknown origin) incubated for 1 hr by HTRF analysis	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12		CHEMBL4514379	>	IC50	nM	15000.0	CHEMBL4267	Homo sapiens	IC50	uM	15.0
Not Active	19040186	CHEMBL4352087	Inhibition of human TGFBR2 (188 to end residues) using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
Active	19041305	CHEMBL4352566	Inhibition of human TGFBR2 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
	19059856	CHEMBL4358157	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	19090420	CHEMBL4365994	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	19092143	CHEMBL4366617	Inhibition of human TGFBR2 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-18.76	CHEMBL4267	Homo sapiens	INH	%	-18.76
	19114490	CHEMBL4371430	Binding affinity to TGFBR2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	1860.0	CHEMBL4267	Homo sapiens	Kd(free)	uM	1.86
	19114702	CHEMBL4371430	Binding affinity to TGFBR2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	7385.0	CHEMBL4267	Homo sapiens	Kd(free)	uM	7.385
Not Active	19138199	CHEMBL4376028	Inhibition of recombinant human N-terminal GST-tagged TGFbeta2 receptor (190 to end residues) expressed in baculovirus infected Sf9 insect cells up to 100 uM using MBP as substrate measured after 2 hrs by ADP-Glo assay	B	C=C(C)[C@@H]1C/C=C(\C)C(=O)CCC2=C[C@@H]1OC2=O		CHEMBL4533719		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
	19144908	CHEMBL4377924	Inhibition of human TGFBR2 (188 to end residues) at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	15.0	CHEMBL4267	Homo sapiens	INH	%	15.0
	19146996	CHEMBL4378978	Inhibition of recombinant human TGFBR2 (188 to end residues) at 10 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamm33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	9.0	CHEMBL4267	Homo sapiens	INH	%	9.0
	19148065	CHEMBL4379461	Inhibition of recombinant human TGFBR2 (188 to end residues) using MBP as substrate incubated for 120 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4267	Homo sapiens	IC50	uM	10.0
	19159684	CHEMBL4382788	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	82.0	CHEMBL4267	Homo sapiens	Activity	%	82.0
	19191323	CHEMBL4389507	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL4267	Homo sapiens	INH	%	100.0
	19192170	CHEMBL4389984	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL4267	Homo sapiens	INH	%	100.0
	19200426	CHEMBL4391610	Binding affinity to wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	19.0	CHEMBL4267	Homo sapiens	Activity	%	19.0
	19266642	CHEMBL4405592	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4267	Homo sapiens	INH	%	50.0
Active	19269496	CHEMBL4406341	Binding affinity to partial length human TGFBR2 expressed in bacterial system at 1 uM by KINOMEscan assay	B	CS(=O)(=O)Nc1ccc(-c2cncc(/C=C3\SC(=N)NC3=O)c2)cc1		CHEMBL4436648		Activity			CHEMBL4267	Homo sapiens	Activity		
Active	19269504	CHEMBL4406346	Inhibition of human TGFBR2 expressed in baculovirus expression system	B	CS(=O)(=O)Nc1ccc(-c2cncc(/C=C3\SC(=N)NC3=O)c2)cc1		CHEMBL4436648		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
Active	19269505	CHEMBL4406346	Inhibition of human TGFBR2 expressed in baculovirus expression system	B	CS(=O)(=O)Nc1ccc(-c2cncc(/C=C3\SC(=O)NC3=O)c2)cc1		CHEMBL4447308		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
Active	19269506	CHEMBL4406346	Inhibition of human TGFBR2 expressed in baculovirus expression system	B	CS(=O)(=O)Nc1ccc(-c2cncc(-c3cccc4[nH]ccc34)c2)cc1		CHEMBL4455633		Inhibition	%		CHEMBL4267	Homo sapiens	INH		
	22423189	CHEMBL4674170	Inhibition of human TGFBR2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	75.47	CHEMBL4267	Homo sapiens	Activity	%	75.47
	22423190	CHEMBL4674170	Inhibition of human TGFBR2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	78.49	CHEMBL4267	Homo sapiens	Activity	%	78.49
	22816624	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(C)nc23)ccn1		CHEMBL4798505	=	IC50	nM	5.0	CHEMBL4267	Homo sapiens	IC50	uM	0.005
	22816625	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(N(C)C)nc23)ccn1		CHEMBL4777071	=	IC50	nM	7.9	CHEMBL4267	Homo sapiens	IC50	uM	0.0079
	22816626	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cnc2c(-c3ccnc(OC)c3)cnn2c1		CHEMBL4750258	=	IC50	nM	15.0	CHEMBL4267	Homo sapiens	IC50	uM	0.015
	22816627	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	CNc1nc2c(-c3ccnc(OC)c3)cnn2cc1OC		CHEMBL4752199	=	IC50	nM	1.0	CHEMBL4267	Homo sapiens	IC50	uM	0.001
	22816628	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	CNc1nc2c(-c3ccnc(OC)c3)cnn2cc1C1CC1		CHEMBL4744988	=	IC50	nM	3.7	CHEMBL4267	Homo sapiens	IC50	uM	0.0037
	22816629	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	CCc1cn2ncc(-c3ccnc(OC)c3)c2nc1NC		CHEMBL4741185	=	IC50	nM	1.5	CHEMBL4267	Homo sapiens	IC50	uM	0.0015
	22816630	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	C=Cc1cn2ncc(-c3ccnc(OC)c3)c2nc1NC		CHEMBL4741913	<	IC50	nM	3.0	CHEMBL4267	Homo sapiens	IC50	uM	0.003
	22816631	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	CNc1nc2c(-c3ccnc(OC)c3)cnn2cc1C		CHEMBL4779579	=	IC50	nM	2.9	CHEMBL4267	Homo sapiens	IC50	uM	0.0029
	22816632	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	CNc1ccn2ncc(-c3ccnc(OC)c3)c2n1		CHEMBL4795223	=	IC50	nM	3.9	CHEMBL4267	Homo sapiens	IC50	uM	0.0039
	22816633	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	CNc1ccn2ncc(-c3cccc(OC)c3)c2n1		CHEMBL4745367	=	IC50	nM	1000.0	CHEMBL4267	Homo sapiens	IC50	uM	1.0
	22816634	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	c1cc2cc(c1)-c1cnn3ccc(nc13)NCCOCCO2		CHEMBL4783244	=	IC50	nM	75.0	CHEMBL4267	Homo sapiens	IC50	uM	0.075
	22816635	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(CNC(=O)Nc2snc(OCc3cccnc3)c2C(N)=O)cc(OC)c1		CHEMBL4747912	=	IC50	nM	110.0	CHEMBL4267	Homo sapiens	IC50	uM	0.11
	22816636	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	Cc1ccc(-c2cnc(N)c(C(=O)NC3CCCCC3)n2)cc1		CHEMBL4792978	=	IC50	nM	490.0	CHEMBL4267	Homo sapiens	IC50	uM	0.49
	22816637	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	CCc1nc2c(-c3ccnc(OC)c3)cnn2cc1OC		CHEMBL4763122	=	IC50	nM	36.0	CHEMBL4267	Homo sapiens	IC50	uM	0.036000000000000004
	22816638	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(C(C)C)nc23)ccn1		CHEMBL4748097	=	IC50	nM	1.0	CHEMBL4267	Homo sapiens	IC50	uM	0.001
	22816639	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(C(C)(C)O)nc23)ccn1		CHEMBL4764416	=	IC50	nM	3.3	CHEMBL4267	Homo sapiens	IC50	uM	0.0033
	22816640	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(C4CCCC4)nc23)ccn1		CHEMBL4782729	=	IC50	nM	1.2	CHEMBL4267	Homo sapiens	IC50	uM	0.0012
	22816641	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(C4CCOC4)nc23)ccn1		CHEMBL4779273	=	IC50	nM	1.1	CHEMBL4267	Homo sapiens	IC50	uM	0.0011
	22816642	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c([C@H]4COC(C)(C)C4)nc23)ccn1		CHEMBL4792464	<	IC50	nM	3.0	CHEMBL4267	Homo sapiens	IC50	uM	0.003
	22816643	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c([C@@H]4COC(C)(C)C4)nc23)ccn1		CHEMBL4749061	=	IC50	nM	3.6	CHEMBL4267	Homo sapiens	IC50	uM	0.0036
	22816644	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(-c4cc(C)no4)nc23)ccn1		CHEMBL4763627	=	IC50	nM	2.9	CHEMBL4267	Homo sapiens	IC50	uM	0.0029
	22816645	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cc(-c2cnn3cc(OC)c(-c4cnn(C)c4)nc23)ccn1		CHEMBL4749011	<	IC50	nM	1.0	CHEMBL4267	Homo sapiens	IC50	uM	0.001
	22816646	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cn2ncc(-c3ccnc(OC(C)C)c3)c2nc1-c1cnn(C)c1		CHEMBL4758580	=	IC50	nM	0.56	CHEMBL4267	Homo sapiens	IC50	uM	0.00056
	22816647	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cn2ncc(-c3ccnc(OC(C)(C)C)c3)c2nc1-c1cnn(C)c1		CHEMBL4747422	=	IC50	nM	7.0	CHEMBL4267	Homo sapiens	IC50	uM	0.006999999999999999
	22816648	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cn2ncc(-c3ccnc(OC4CC4)c3)c2nc1-c1cnn(C)c1		CHEMBL4744618	=	IC50	nM	1.6	CHEMBL4267	Homo sapiens	IC50	uM	0.0016
	22816649	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	COc1cn2ncc(-c3ccnc(OC4CCC4)c3)c2nc1-c1cnn(C)c1		CHEMBL4787891	=	IC50	nM	0.61	CHEMBL4267	Homo sapiens	IC50	uM	0.00061
	22816650	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	Cn1cc(-c2nc3c(-c4ccnc(OC5CC5)c4)cnn3cc2OCC(C)(C)O)cn1		CHEMBL4791414	=	IC50	nM	0.31	CHEMBL4267	Homo sapiens	IC50	uM	0.00031
	22816651	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	Cn1cc(-c2nc3c(-c4ccnc(OC5CC5)c4)cnn3cc2OCCC(C)(C)O)cn1		CHEMBL4751832	=	IC50	nM	0.83	CHEMBL4267	Homo sapiens	IC50	uM	0.0008300000000000001
	22816652	CHEMBL4714984	Inhibition of TGFbeta receptor 2 (unknown origin) using biotin-labelled TTLKDLIYDMTTSGSGSGLPLLVQRTIARTsubstrate in presence of [gamma33P] ATP measured after 50 min	B	Cn1cc(-c2nc3c(-c4ccnc(OC5CC5)c4)cnn3cc2OCCCC(C)(C)O)cn1		CHEMBL4764221	=	IC50	nM	2.0	CHEMBL4267	Homo sapiens	IC50	uM	0.002
	22843885	CHEMBL4720871	Inhibition of human TGFBR2 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	121.84	CHEMBL4267	Homo sapiens	Activity	%	121.84
	22844882	CHEMBL4721557	Inhibition of wild-type human partial length TGFBR2 (I218 to K567 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	103.65	CHEMBL4267	Homo sapiens	Activity	%	103.65
	22884290	CHEMBL4727760	Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2ccccc2n1		CHEMBL4740381	=	IC50	nM	1250.0	CHEMBL4267	Homo sapiens	IC50	nM	1250.0
	22884291	CHEMBL4727760	Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4788859	=	IC50	nM	587.2	CHEMBL4267	Homo sapiens	IC50	nM	587.2
	22884292	CHEMBL4727760	Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4786529	=	IC50	nM	170.7	CHEMBL4267	Homo sapiens	IC50	nM	170.7
	22884293	CHEMBL4727760	Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2ccccc2n1		CHEMBL4742906	=	IC50	nM	4590.0	CHEMBL4267	Homo sapiens	IC50	nM	4590.0
	22884294	CHEMBL4727760	Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4778971	=	IC50	nM	498.0	CHEMBL4267	Homo sapiens	IC50	nM	498.0
	22886509	CHEMBL4728246	Binding affinity to TGFBR2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	6.0	CHEMBL4267	Homo sapiens	deltaTm	degrees C	6.0
	23122841	CHEMBL4805192	Inhibition of human TGFBR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	96.0	CHEMBL4267	Homo sapiens	Activity	%	96.0
	23123536	CHEMBL4805780	Inhibition of human TGFBR2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	94.0	CHEMBL4267	Homo sapiens	Activity	%	94.0
	23123988	CHEMBL4806232	Inhibition of DNA-tagged human TGFBR2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	94.0	CHEMBL4267	Homo sapiens	Activity	%	94.0
	23125162	CHEMBL4806797	Inhibition of human TGFBR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	23125163	CHEMBL4806797	Inhibition of human TGFBR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4267	Homo sapiens	Activity	%	100.0
	23128641	CHEMBL4808022	Inhibition of TGFB-R2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL4267	Homo sapiens	Activity	%	50.0
	23128642	CHEMBL4808022	Inhibition of TGFB-R2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4267	Homo sapiens	Activity	%	75.0
	23128643	CHEMBL4808022	Inhibition of TGFB-R2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	50.0	CHEMBL4267	Homo sapiens	Activity	%	50.0
	23213445	CHEMBL4822979	Inhibition of human recombinant TGFBR2 by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	20.0	CHEMBL4267	Homo sapiens	INH	%	20.0
	23248243	CHEMBL4830420	Inhibition of human TGFBR2 using MBP as substrate assessed as enzyme activity incubated for 2 hrs by [gamma-33P]-ATP assay relative to control	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	<	Activity	%	20.0	CHEMBL4267	Homo sapiens	Activity	%	20.0
Not Active	23317677	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	74.0	CHEMBL4267	Homo sapiens	% Control	%	74.0
Not Active	23318145	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	97.0	CHEMBL4267	Homo sapiens	% Control	%	97.0
Not Active	23318811	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23319295	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL4267	Homo sapiens	% Control	%	96.0
Not Active	23319931	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23320407	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	98.6	CHEMBL4267	Homo sapiens	% Control	%	98.6
Not Active	23321085	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	88.0	CHEMBL4267	Homo sapiens	% Control	%	88.0
Not Active	23321553	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	99.0	CHEMBL4267	Homo sapiens	% Control	%	99.0
Not Active	23322183	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	95.0	CHEMBL4267	Homo sapiens	% Control	%	95.0
Not Active	23322651	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL4267	Homo sapiens	% Control	%	96.0
Not Active	23323340	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	87.0	CHEMBL4267	Homo sapiens	% Control	%	87.0
Not Active	23323808	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23324662	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	74.6	CHEMBL4267	Homo sapiens	% Control	%	74.6
Not Active	23325297	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23325765	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23326412	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	87.0	CHEMBL4267	Homo sapiens	% Control	%	87.0
Not Active	23326880	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	64.0	CHEMBL4267	Homo sapiens	% Control	%	64.0
Not Active	23327580	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23328048	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	71.0	CHEMBL4267	Homo sapiens	% Control	%	71.0
Not Active	23328635	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23329103	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23329551	CHEMBL4881258	TGFBR2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	108.0	CHEMBL4267	Homo sapiens	% residual kinase activity	%	108.0
Not Active	23330049	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	88.0	CHEMBL4267	Homo sapiens	% Control	%	88.0
Not Active	23330517	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL4267	Homo sapiens	% Control	%	93.0
Not Active	23331273	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23331741	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23332328	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	78.6	CHEMBL4267	Homo sapiens	% Control	%	78.6
Not Active	23332794	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	94.5	CHEMBL4267	Homo sapiens	% Control	%	94.5
Not Active	23333512	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	67.8	CHEMBL4267	Homo sapiens	% Control	%	67.8
Not Active	23334151	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	91.0	CHEMBL4267	Homo sapiens	% Control	%	91.0
Not Active	23334619	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	97.0	CHEMBL4267	Homo sapiens	% Control	%	97.0
Not Active	23335598	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23336066	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	90.0	CHEMBL4267	Homo sapiens	% Control	%	90.0
Not Active	23336693	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23337161	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23338242	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	88.0	CHEMBL4267	Homo sapiens	% Control	%	88.0
Not Active	23338710	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23339322	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23339790	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23340427	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23340895	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	96.0	CHEMBL4267	Homo sapiens	% Control	%	96.0
Not Active	23341552	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23342020	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23342636	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	89.0	CHEMBL4267	Homo sapiens	% Control	%	89.0
Not Active	23343104	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23343734	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	66.0	CHEMBL4267	Homo sapiens	% Control	%	66.0
Not Active	23344202	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23344840	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23345413	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	93.0	CHEMBL4267	Homo sapiens	% Control	%	93.0
Not Active	23345881	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	85.0	CHEMBL4267	Homo sapiens	% Control	%	85.0
Slightly Active	23346457	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	49.5	CHEMBL4267	Homo sapiens	% Control	%	49.5
Not Active	23346926	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Slightly Active	23347586	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	40.8	CHEMBL4267	Homo sapiens	% Control	%	40.8
Not Active	23347587	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174	=	Kd	nM	54.0	CHEMBL4267	Homo sapiens	Kd	nM	54.0
Not Active	23348018	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	76.1	CHEMBL4267	Homo sapiens	% Control	%	76.1
Not Active	23348597	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23349065	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23349652	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23350270	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23350738	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23351343	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23351811	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	67.0	CHEMBL4267	Homo sapiens	% Control	%	67.0
Not Active	23352835	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23353303	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	73.0	CHEMBL4267	Homo sapiens	% Control	%	73.0
Not Active	23354185	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23354653	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23355385	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	94.0	CHEMBL4267	Homo sapiens	% Control	%	94.0
Not Active	23355853	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	97.0	CHEMBL4267	Homo sapiens	% Control	%	97.0
Not Active	23356489	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23356957	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23357566	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23358213	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	76.0	CHEMBL4267	Homo sapiens	% Control	%	76.0
Not Active	23358681	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23359267	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	97.0	CHEMBL4267	Homo sapiens	% Control	%	97.0
Not Active	23359865	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23360333	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23360918	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	81.0	CHEMBL4267	Homo sapiens	% Control	%	81.0
Not Active	23361386	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	92.0	CHEMBL4267	Homo sapiens	% Control	%	92.0
Not Active	23361959	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	99.0	CHEMBL4267	Homo sapiens	% Control	%	99.0
Not Active	23362495	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23362963	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23364605	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	74.0	CHEMBL4267	Homo sapiens	% Control	%	74.0
Not Active	23365073	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	76.0	CHEMBL4267	Homo sapiens	% Control	%	76.0
Not Active	23365812	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	83.0	CHEMBL4267	Homo sapiens	% Control	%	83.0
Not Active	23366355	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23366945	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	99.0	CHEMBL4267	Homo sapiens	% Control	%	99.0
Not Active	23367413	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23367764	CHEMBL4884117	TGFB-R2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	77.0	CHEMBL4267	Homo sapiens	% Residual activity with Skepinone-L	%	77.0
Not Active	23368291	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23368759	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	91.0	CHEMBL4267	Homo sapiens	% Control	%	91.0
Not Active	23369358	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	98.0	CHEMBL4267	Homo sapiens	% Control	%	98.0
Not Active	23369826	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	85.0	CHEMBL4267	Homo sapiens	% Control	%	85.0
Not Active	23370794	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	82.0	CHEMBL4267	Homo sapiens	% Control	%	82.0
Not Active	23371262	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL4267	Homo sapiens	% Control	%	99.0
Not Active	23372071	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	91.0	CHEMBL4267	Homo sapiens	% Control	%	91.0
Not Active	23372539	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	93.0	CHEMBL4267	Homo sapiens	% Control	%	93.0
	23372915	CHEMBL4884880	TGFbetaR2(TGF2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4267	Homo sapiens	pIC50		6.0
	23373324	CHEMBL4885171	TGFbetaR2(TGF2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4267	Homo sapiens	pIC50		6.0
	23373678	CHEMBL4885455	TGFbetaR2(TGF2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4267	Homo sapiens	pIC50		6.0
Not Active	23375966	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	98.0	CHEMBL4267	Homo sapiens	% Control	%	98.0
Not Active	23376434	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23377011	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23377479	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	85.0	CHEMBL4267	Homo sapiens	% Control	%	85.0
Not Active	23378339	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	90.0	CHEMBL4267	Homo sapiens	% Control	%	90.0
Not Active	23378807	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	95.0	CHEMBL4267	Homo sapiens	% Control	%	95.0
Not Active	23379974	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	93.0	CHEMBL4267	Homo sapiens	% Control	%	93.0
Not Active	23380442	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	93.0	CHEMBL4267	Homo sapiens	% Control	%	93.0
Not Active	23381136	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23381784	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23382252	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	99.0	CHEMBL4267	Homo sapiens	% Control	%	99.0
Not Active	23382876	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23383344	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23383674	CHEMBL4887330	TGFBR2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	87.0	CHEMBL4267	Homo sapiens	% Ctrl	%	87.0
Not Active	23384489	CHEMBL4888084	TGFBR2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	19.28	CHEMBL4267	Homo sapiens	% inhibition	%	19.28
Not Active	23385259	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
Not Active	23385726	CHEMBL4879983	KinomeScan assay: inhibition of TGFBR2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4267	Homo sapiens	% Control	%	100.0
